BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xie LQ, Yu JP, Luo HS. Expression of estrogen receptor β in human colorectal cancer. World J Gastroenterol 2004; 10(2): 214-217 [PMID: 14716825 DOI: 10.3748/wjg.v10.i2.214] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 31] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Das PK, Saha J, Pillai S, Lam AK, Gopalan V, Islam F. Implications of estrogen and its receptors in colorectal carcinoma. Cancer Med 2022. [PMID: 36207986 DOI: 10.1002/cam4.5242] [Reference Citation Analysis]
2 Rasheed S, Rehman K, Shahid M, Suhail S, Akash MSH. Therapeutic potentials of genistein: New insights and perspectives. J Food Biochem 2022;:e14228. [PMID: 35579327 DOI: 10.1111/jfbc.14228] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
3 Topi G, Ghatak S, Satapathy SR, Ehrnström R, Lydrup M, Sjölander A. Combined Estrogen Alpha and Beta Receptor Expression Has a Prognostic Significance for Colorectal Cancer Patients. Front Med 2022;9:739620. [DOI: 10.3389/fmed.2022.739620] [Reference Citation Analysis]
4 Ditonno I, Losurdo G, Rendina M, Pricci M, Girardi B, Ierardi E, Di Leo A. Estrogen Receptors in Colorectal Cancer: Facts, Novelties and Perspectives. Curr Oncol 2021;28:4256-63. [PMID: 34898546 DOI: 10.3390/curroncol28060361] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
5 Mahadik N, Bhattacharya D, Padmanabhan A, Sakhare K, Narayan KP, Banerjee R. Targeting steroid hormone receptors for anti-cancer therapy-A review on small molecules and nanotherapeutic approaches. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2021;:e1755. [PMID: 34541822 DOI: 10.1002/wnan.1755] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Shaheer K, Somashekarappa HM, Lakshmanan MD. Piperine sensitizes radiation-resistant cancer cells towards radiation and promotes intrinsic pathway of apoptosis. J Food Sci 2020;85:4070-9. [PMID: 33089532 DOI: 10.1111/1750-3841.15496] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
7 Maingi JW, Tang S, Liu S, Ngenya W, Bao E. Targeting estrogen receptors in colorectal cancer. Mol Biol Rep 2020;47:4087-91. [PMID: 32246248 DOI: 10.1007/s11033-020-05414-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
8 Abd ElLateef AAE, Mohamed AES, Elhakeem AA, Ahmed SF. Estrogen and Progesterone Expression in Colorectal Carcinoma: A Clinicopathological Study. Asian Pac J Cancer Prev 2020;21:1155-62. [PMID: 32334485 DOI: 10.31557/APJCP.2020.21.4.1155] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
9 Herichova I, Reis R, Hasakova K, Vician M, Zeman M. Sex-dependent regulation of estrogen receptor beta in human colorectal cancer tissue and its relationship with clock genes and VEGF-A expression. Physiol Res 2019;68:S297-305. [PMID: 31928047 DOI: 10.33549/physiolres.934352] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
10 Pérez-ruiz E, Rueda A, Pérez L, Rivas-ruiz F, Torres E, de Luque V, Álvarez M, Sevilla I, Redondo M, Padilla-ruiz M, Alba E, Alonso L. Expression and Prognostic Value of Oestrogen Receptor Beta in Colorectal Cancer. Pathol Oncol Res 2018;24:871-9. [DOI: 10.1007/s12253-017-0301-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
11 Frycz BA, Murawa D, Borejsza-Wysocki M, Wichtowski M, Spychała A, Marciniak R, Murawa P, Drews M, Jagodziński PP. mRNA expression of steroidogenic enzymes, steroid hormone receptors and their coregulators in gastric cancer. Oncol Lett 2017;13:3369-78. [PMID: 28521442 DOI: 10.3892/ol.2017.5881] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
12 Williams C, DiLeo A, Niv Y, Gustafsson JÅ. Estrogen receptor beta as target for colorectal cancer prevention. Cancer Lett 2016;372:48-56. [PMID: 26708506 DOI: 10.1016/j.canlet.2015.12.009] [Cited by in Crossref: 98] [Cited by in F6Publishing: 94] [Article Influence: 12.3] [Reference Citation Analysis]
13 Tillmans LS, Vierkant RA, Wang AH, Samadder NJ, Lynch CF, Anderson KE, French AJ, Haile RW, Harnack LJ, Potter JD, Slager SL, Smyrk TC, Thibodeau SN, Cerhan JR, Limburg PJ. Associations between Environmental Exposures and Incident Colorectal Cancer by ESR2 Protein Expression Level in a Population-Based Cohort of Older Women. Cancer Epidemiol Biomarkers Prev 2015;24:713-9. [PMID: 25650184 DOI: 10.1158/1055-9965.EPI-14-0756] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
14 Caiazza F, Ryan EJ, Doherty G, Winter DC, Sheahan K. Estrogen receptors and their implications in colorectal carcinogenesis. Front Oncol. 2015;5:19. [PMID: 25699240 DOI: 10.3389/fonc.2015.00019] [Cited by in Crossref: 106] [Cited by in F6Publishing: 115] [Article Influence: 13.3] [Reference Citation Analysis]
15 Janakiram NB, Mohammed A, Zhang Y, Brewer M, Bryant T, Lightfoot S, Steele VE, Rao CV. Chemopreventive efficacy of raloxifene, bexarotene, and their combination on the progression of chemically induced colon adenomas to adenocarcinomas in rats. Cancer Prev Res (Phila) 2013;6:1251-61. [PMID: 24080207 DOI: 10.1158/1940-6207.CAPR-13-0249] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
16 Elbanna HG, Ebrahim MA, Abbas AM, Zalata K, Hashim MA. Potential value of estrogen receptor beta expression in colorectal carcinoma: interaction with apoptotic index. J Gastrointest Cancer. 2012;43:56-62. [PMID: 20872292 DOI: 10.1007/s12029-010-9214-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
17 Wangefjord S, Manjer J, Gaber A, Nodin B, Eberhard J, Jirström K. Cyclin D1 expression in colorectal cancer is a favorable prognostic factor in men but not in women in a prospective, population-based cohort study. Biol Sex Differ 2011;2:10. [PMID: 21888663 DOI: 10.1186/2042-6410-2-10] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
18 Solimando R, Bazzoli F, Ricciardiello L. Chemoprevention of colorectal cancer: a role for ursodeoxycholic acid, folate and hormone replacement treatment? Best Pract Res Clin Gastroenterol 2011;25:555-68. [PMID: 22122771 DOI: 10.1016/j.bpg.2011.09.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
19 Wu CC, Tsai FM, Shyu RY, Tsai YM, Wang CH, Jiang SY. G protein-coupled receptor kinase 5 mediates Tazarotene-induced gene 1-induced growth suppression of human colon cancer cells. BMC Cancer 2011;11:175. [PMID: 21575264 DOI: 10.1186/1471-2407-11-175] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.4] [Reference Citation Analysis]
20 Gordon MA, Zhang W, Yang D, Iqbal S, El-Khouiery A, Nagashima F, Lurje G, Labonte M, Wilson P, Sherrod A, Ladner RD, Lenz HJ. Gender-specific genomic profiling in metastatic colorectal cancer patients treated with 5-fluorouracil and oxaliplatin. Pharmacogenomics 2011;12:27-39. [PMID: 21174620 DOI: 10.2217/pgs.10.163] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
21 Johnsen NF, Olsen A, Thomsen BLR, Christensen J, Egeberg R, Bach Knudsen KE, Loft S, Overvad K, Tjønneland A. Plasma enterolactone and risk of colon and rectal cancer in a case–cohort study of Danish men and women. Cancer Causes Control 2010;21:153-62. [DOI: 10.1007/s10552-009-9445-5] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
22 Mostafaie N, Kállay E, Sauerzapf E, Bonner E, Kriwanek S, Cross HS, Huber KR, Krugluger W. Correlated downregulation of estrogen receptor beta and the circadian clock gene Per1 in human colorectal cancer. Mol Carcinog. 2009;48:642-647. [PMID: 19148895 DOI: 10.1002/mc.20510] [Cited by in Crossref: 66] [Cited by in F6Publishing: 73] [Article Influence: 4.7] [Reference Citation Analysis]
23 Hogan AM, Collins D, Baird AW, Winter DC. Estrogen and gastrointestinal malignancy. Mol Cell Endocrinol. 2009;307:19-24. [PMID: 19524122 DOI: 10.1016/j.mce.2009.03.016] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 2.1] [Reference Citation Analysis]
24 Tzelepi V, Grivas P, Kefalopoulou Z, Kalofonos H, Varakis JN, Melachrinou M, Sotiropoulou-bonikou G. Estrogen signaling in colorectal carcinoma microenvironment: expression of ERβ1, AIB-1, and TIF-2 is upregulated in cancer-associated myofibroblasts and correlates with disease progression. Virchows Arch 2009;454:389-99. [DOI: 10.1007/s00428-009-0740-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
25 Martineti V, Silvestri S, Tonelli F, Brandi ML. Control of colon cancer development and progression by selected estrogen receptor modulators. Expert Rev Endocrinol Metab 2008;3:503-11. [PMID: 30290437 DOI: 10.1586/17446651.3.4.503] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
26 Kennelly R, Kavanagh DO, Hogan AM, Winter DC. Oestrogen and the colon: potential mechanisms for cancer prevention. Lancet Oncol. 2008;9:385-391. [PMID: 18374292 DOI: 10.1016/s1470-2045(08)70100-1] [Cited by in Crossref: 112] [Cited by in F6Publishing: 114] [Article Influence: 7.5] [Reference Citation Analysis]
27 Janakiram NB, Rao CV. Molecular markers and targets for colorectal cancer prevention. Acta Pharmacol Sin 2008;29:1-20. [PMID: 18158862 DOI: 10.1111/j.1745-7254.2008.00742.x] [Cited by in Crossref: 76] [Cited by in F6Publishing: 79] [Article Influence: 5.1] [Reference Citation Analysis]
28 Nylander-Koski O, Kiviluoto T, Puolakkainen P, Kivilaakso E, Mustonen H. The effect of nitric oxide, growth factors, and estrogen on gastric cell migration. J Surg Res 2007;143:230-7. [PMID: 17950324 DOI: 10.1016/j.jss.2006.12.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
29 Deyrup AT, Tretiakova M, Khramtsov A, Montag AG. Estrogen receptor β expression in vascular neoplasia: an analysis of 53 benign and malignant cases. Mod Pathol 2004;17:1372-7. [DOI: 10.1038/modpathol.3800201] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]